Encorafenib

ATC L01EC03 · 10 markets · 19 records

Encorafenib 10 markets · 19 records Forms

AU 5 records · 3 strengths

75 mgcapsuleBRAFTOVI+1BRAFTOVI encorafenib 75 mg capsule blister pack also in GB·SG·ES +3 unknown
50 mgcapsuleBRAFTOVI+1BRAFTOVI encorafenib 75 mg capsule blister pack also in GB·SG·ES unknown

Records without a stated strength · 1 BRAFTOVI

GB 3 records · 2 strengths

75 mgcapsuleBRAFTOVI also in AU·SG·ES +3
50 mgcapsuleBRAFTOVI also in AU·SG·ES

SG 2 records · 2 strengths

75 mgcapsuleBraftovi 75 mg hard capsules also in AU·GB·ES +3
50 mgcapsuleBraftovi 75 mg hard capsules also in AU·GB·ES

ES 2 records · 2 strengths

75 mgcapsuleBRAFTOVI also in AU·GB·SG +3
50 mgcapsuleBRAFTOVI also in AU·GB·SG

HK 2 records · 1 strengths

Records without a stated strength · 1 BRAFTOVI

US 1 records · 1 strengths

75 mgcapsuleBRAFTOVI also in AU·GB·SG +3

CA 1 records · 1 strengths

75 mgcapsuleBRAFTOVI also in AU·GB·SG +3

MX 1 records · 1 strengths

Records without a stated strength · 1 BRAFTOVI

TW 1 records · 1 strengths

75 mgcapsuleBraftovi 75 mg hard capsules+1迫癌癒 75 毫克膠囊 also in AU·GB·SG +3

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 BRAFTOVI

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
75 mg capsule	BRAFTOVI	BRAFTOVI	BRAFTOVI	BRAFTOVI BRAFTOVI encorafenib 75 mg capsule blister pack	Braftovi 75 mg hard capsules	BRAFTOVI	not recorded	Braftovi 75 mg hard capsules 迫癌癒 75 毫克膠囊	not recorded	not recorded
50 mg capsule	not recorded	BRAFTOVI	not recorded	BRAFTOVI BRAFTOVI encorafenib 75 mg capsule blister pack	Braftovi 75 mg hard capsules	BRAFTOVI	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	BRAFTOVI	not recorded	not recorded	not recorded	not recorded	BRAFTOVI	BRAFTOVI
not disclosed capsule	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	BRAFTOVI	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录（未在本表显示）。另有 1 個規格/劑型僅在 MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.